Press Releases
WASHINGTON, D.C. - U.S. Representatives Anna G. Eshoo (D-CA) and Drew Ferguson (R-GA) and U.S.
WASHINGTON, D.C. – U.S. Rep. Anna G. Eshoo (CA-18), a member of the Gun Violence Prevention Task Force, voted for two major gun safety bills, H.R. 1446, the Enhanced Background Check Act, and H.R. 8, the Bipartisan Background Checks Act.
WASHINGTON, D.C. – U.S. Rep. Anna G. Eshoo (CA-18), Chairwoman of the Energy and Commerce Health Subcommittee, voted for final passage of H.R.
WASHINGTON, D.C. – U.S. Reps. Anna G. Eshoo (D-CA), Jared Golden (D-ME) and U.S.
WASHINGTON, D.C. — Today U.S. Rep. Anna G. Eshoo (CA-18) announced this year's district-wide Congressional Art Competition to discover and celebrate talented high school artists and their work. Due to COVID, the competition will be held virtually and students will submit their art for judging online.
H.R. 1 Includes Eshoo’s Provisions to Make Election Day a Federal Holiday and Mandate Release of President’s Tax Returns
WASHINGTON, D.C. – U.S Rep. Anna G. Eshoo (CA-18) voted to pass H.R. 1, the For the People Act, a sweeping anti-corruption package to protect and expand voting rights, restore integrity to government, reform our campaign finance system, and put the needs and priorities of the American people first.
WASHINGTON, D.C. – Today, U.S. Rep. Anna G. Eshoo (CA-18), Chairwoman of the Energy and Commerce Health Subcommittee, met with President Biden, Vice President Harris, and a bipartisan, bicameral group of lawmakers to discuss new federal investments in the early detection and research of America’s deadliest diseases.
WASHINGTON, D.C. – Today U.S. Rep. Anna G. Eshoo (CA-18) voted to pass the George Floyd Justice in Policing Act, historic legislation to hold police accountable, end racial profiling, change the culture of law enforcement, and build trust between law enforcement and communities by addressing systemic racism and bias.
WASHINGTON, D.C. – U.S. Rep. Anna G. Eshoo (CA-18), Chairwoman of the Energy and Commerce Health Subcommittee, released the following statement today after the Food and Drug Administration (FDA) granted an emergency use authorization for Johnson & Johnson’s COVID-19 vaccine: